标题
Vancomycin-Associated Renal Dysfunction: Where Are We Now?
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 34, Issue 12, Pages 1259-1268
出版商
Wiley
发表日期
2014-09-15
DOI
10.1002/phar.1488
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of three generic vancomycin products using liquid chromatography-mass spectrometry and an online tool
- (2014) P. O. Lewis et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin
- (2014) Diane Cappelletty et al. CLINICAL DRUG INVESTIGATION
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam
- (2014) Lindsey D. Burgess et al. PHARMACOTHERAPY
- Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
- (2014) Diane M. Gomes et al. PHARMACOTHERAPY
- Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors
- (2014) Calvin J. Meaney et al. PHARMACOTHERAPY
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
- (2013) Michael N. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review
- (2013) P. Tattevin et al. CLINICAL INFECTIOUS DISEASES
- Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
- (2013) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with cefepime
- (2013) R.P. Moenster et al. CLINICAL MICROBIOLOGY AND INFECTION
- Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals
- (2013) Susan L. Davis et al. PHARMACOTHERAPY
- The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
- (2013) Jinjian Fu et al. PLoS One
- Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
- (2013) Ronald G Hall et al. BMC Pharmacology & Toxicology
- The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis
- (2012) Amy Horey et al. ANNALS OF PHARMACOTHERAPY
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
- (2012) S. J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits
- (2012) P. Tattevin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
- (2012) Yosuke Suzuki et al. CHEMOTHERAPY
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database
- (2012) Ennie L. Cano et al. CLINICAL THERAPEUTICS
- Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
- (2012) Sepideh Elyasi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of continuous infusion of vancomycin for the outpatient treatment of methicillin-resistant Staphylococcus aureus infections
- (2012) A. J. Verrall et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort
- (2012) Ravina Kullar et al. PHARMACOTHERAPY
- Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients
- (2011) Emi Minejima et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial
- (2011) John A. Bosso et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
- (2011) M. A. Cataldo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans
- (2011) Kavitha K. Prabaker et al. Journal of Hospital Medicine
- Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
- (2010) Lindsey Pritchard et al. AMERICAN JOURNAL OF MEDICINE
- Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
- (2010) Allan J. Walkey et al. CHEST
- ACUTE KIDNEY INJURY CLASSIFICATION
- (2010) Chih-Hsiang Chang et al. SHOCK
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Reduced Vancomycin Clearance Despite Unchanged Creatinine Clearance in Patients Treated With Vancomycin For Longer Than 4 Weeks
- (2009) Hirokazu Nakayama et al. THERAPEUTIC DRUG MONITORING
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The RIFLE criteria and mortality in acute kidney injury: A systematic review
- (2007) Z. Ricci et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started